Melanocyte-secreted fibromodulin constrains skin inflammation in mice injected with lupus serum

Marianna Halasi, Abraham Nyska, Limor Rubin, Yuval Tal, George C. Tsokos, Irit Adini*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Skin pigmentation has been linked to the development, prevalence, and severity of several immune-mediated diseases such as SLE. Here, we asked whether fibromodulin (FMOD), which is highly expressed in skin with light complexion, can explain the known differences in the magnitude of inflammation. C57 mice with different levels of pigmentation and FMOD were injected with human lupus serum to induce skin inflammation. Histopathologic studies revealed that black C57 FMOD+/+ that produce low levels of FMOD and white C57 FMOD −/− mice develop more severe inflammation compared with white FMOD +/+ mice. This study also revealed that dark pigmentation and FMOD deletion correlates with the increased numbers of Langerhans cells. Altogether, we identify low pigmentation and FMOD are linked to low severity of inflammation and approaches to promote FMOD expression should offer clinical benefit.

Original languageEnglish
Article number109055
JournalClinical Immunology
Volume241
DOIs
StatePublished - Aug 2022
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2022 Elsevier Inc.

Keywords

  • Fibromodulin
  • Langerhans cells
  • Lupus serum
  • Melanocytes
  • Pigment

Fingerprint

Dive into the research topics of 'Melanocyte-secreted fibromodulin constrains skin inflammation in mice injected with lupus serum'. Together they form a unique fingerprint.

Cite this